Rhythm Pharmaceuticals Cash Flow Statement (2016-2026) | RYTM

Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-38.31M-54.07M-55.33M-47.42M-40.86M-42.49M-52.18M-46.70M-44.16M-41.63M-141.37M-32.28M-43.64M-43.33M-49.52M-46.59M-52.90M-47.51M-55.59M-49.30M
Share-based Compensation (Quarter)
5.27M4.68M4.61M5.14M4.80M5.29M6.38M8.89M8.61M8.67M7.77M10.36M11.00M10.56M28.74M18.81M19.27M8.46M26.06M
Deferred Taxes (Quarter)
-8.99M
Cash from Operations (Quarter)
-40.16M-40.47M-53.63M-38.81M-46.99M-34.00M-36.43M-41.09M-29.25M-29.38M-40.74M-29.08M-25.21M-18.84M-40.35M-23.31M-26.62M-25.39M-44.19M-9.15M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
3.15M4.02M4.01M5.91M5.24M5.45M5.41M5.82M4.74M4.62M4.58M4.54M
Depreciation & Amortization (CF) (Quarter)
0.32M
Change in Working Capital
Change in Receivables (Quarter)
0.60M2.90M1.89M5.71M0.71M0.33M-0.17M2.90M1.71M-0.79M-0.69M7.83M6.60M-6.17M8.11M6.22M
Change in Inventory (Quarter)
-0.01M1.23M2.57M0.69M1.58M0.86M-0.12M3.49M1.90M4.85M0.57M-0.48M2.45M4.93M3.09M2.34M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
5.99M12.92M-0.05M-1.55M-12.57M15.71M5.17M0.66M4.09M4.86M-1.25M0.48M7.51M15.18M-3.63M13.26M11.02M1.25M-5.62M16.46M
Other Working Capital Changes (Quarter)
-2.96M4.93M-0.95M-1.75M3.18M-0.97M-0.01M-0.14M-2.73M2.42M-2.71M0.11M0.18M-1.29M0.19M0.49M-2.80M
Investing Activities
Capital Expenditures (Quarter)
10.27M1.28M0.13M0.06M4.65M-4.56M0.10M-1.22M-0.54M0.00M-1.20M-1.05M-0.91M3.16M-0.10M-5.42M5.24M0.68M-0.43M
Change in Acquisitions & Divestments (Quarter)
156.66M69.05M112.13M51.00M61.48M59.64M92.67M124.50M74.50M63.29M70.05M57.75M45.30M87.53M58.33M80.99M61.50M51.65M99.25M57.50M
Cash from Investing Activities (Quarter)
62.78M7.25M72.52M35.98M-39.70M-40.77M18.46M48.19M-94.96M22.64M30.05M-8.56M-90.82M21.16M24.81M54.03M-246.35M30.35M57.05M14.01M
Financing Activities
Other financing activities (Quarter)
-3.23M0.40M3.46M-3.24M0.55M0.34M1.58M-2.47M6.35M1.40M-6.49M7.63M0.85M4.82M5.49M177.50M1.25M7.00M
Cash from Financing Activities (Quarter)
0.41M0.10M0.40M37.50M158.56M17.36M-0.13M-0.96M73.04M2.42M4.24M146.18M2.49M38.33M32.50M-0.89M189.30M-2.95M-5.40M-1.17M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-0.01M14.14M-48.88M34.03M154.62M-188.66M
Additional items
Exchange Rate Effect (Quarter)
0.09M-0.11M0.08M-0.19M-0.07M-0.30M-0.60M0.98M-0.00M-0.28M0.30M0.06M0.45M-0.22M
Change in Cash (Quarter)
23.03M-33.12M19.29M34.67M71.88M-57.41M-18.02M6.02M-51.09M-4.51M-6.52M108.24M-114.14M41.62M16.96M29.55M-83.36M2.07M7.92M3.48M
Free Cash Flow (Quarter)
-50.43M-41.75M-53.76M-38.87M-51.64M-29.44M-36.53M-39.87M-28.71M-29.39M-39.55M-28.02M-24.31M-22.00M-40.25M-17.89M-31.86M-26.07M-43.75M-9.15M
Net Cash Flow (Quarter)
23.03M-33.12M19.29M34.67M71.88M-57.41M-18.10M6.14M-51.17M-4.32M-6.45M108.54M-113.54M40.64M16.96M29.83M-83.67M2.01M7.47M3.70M